Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.
Day One Biopharmaceuticals Inc (NASDAQ: DAWN) closed the day trading at $14.92 up 12.94% from the previous closing price of $13.21. In other words, the price has increased by $12.94 from its previous closing price. On the day, 3.6 million shares were traded. DAWN stock price reached its highest trading level at $15.1 during the session, while it also had its lowest trading level at $13.2291.
Ratios:
For a better understanding of DAWN, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 12.72 and its Current Ratio is at 12.72. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Needham on April 24, 2024, Reiterated its Buy rating but revised its target price to $33 from $30 previously.
On April 25, 2023, BofA Securities Downgraded its rating to Underperform which previously was Buy and also lowered its target price recommendation from $34 to $9.
On February 08, 2023, CapitalOne started tracking the stock assigning a Overweight rating and target price of $40.CapitalOne initiated its Overweight rating on February 08, 2023, with a $40 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Apr 18 ’24 when Blackman Samuel C. sold 10,000 shares for $16.02 per share. The transaction valued at 160,163 led to the insider holds 1,174,662 shares of the business.
Blackman Samuel C. sold 10,000 shares of DAWN for $160,055 on Mar 25 ’24. The HEAD OF R&D now owns 1,184,662 shares after completing the transaction at $16.01 per share. On Mar 11 ’24, another insider, Blackman Samuel C., who serves as the HEAD OF R&D of the company, sold 30,000 shares for $15.24 each. As a result, the insider received 457,314 and left with 1,194,662 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, DAWN now has a Market Capitalization of 1303667840 and an Enterprise Value of 937843072.
Stock Price History:
Over the past 52 weeks, DAWN has reached a high of $17.85, while it has fallen to a 52-week low of $9.67. The 50-Day Moving Average of the stock is -1.83%, while the 200-Day Moving Average is calculated to be 10.13%.
Shares Statistics:
Over the past 3-months, DAWN traded about 917.05K shares per day on average, while over the past 10 days, DAWN traded about 2482400 shares per day. A total of 87.23M shares are outstanding, with a floating share count of 59.28M. Insiders hold about 32.54% of the company’s shares, while institutions hold 76.22% stake in the company. Shares short for DAWN as of 1713139200 were 8941942 with a Short Ratio of 9.75, compared to 1710460800 on 9608728. Therefore, it implies a Short% of Shares Outstanding of 8941942 and a Short% of Float of 12.770000000000001.
